Copy
See below for a daily digest of the latest Parkinson's Disease news & perspectives!

Student-Developed Wearable ‘Tremor Tracker’ Monitors Parkinson’s Tremors

Feb 07, 2020 07:00 am | Steve Bryson PhD

 

Tremor TrackerTwo Louisiana Tech University biomedical engineering students designed a wearable medical device that can track and classify Parkinson’s disease tremors and their severity.  Julie Gaudin and Elizabeth Hummel created the Tremor Tracker, a smart watch-like device that captures and immediately conveys information about body movements, as part of their senior design class. “Through supervised machine […]

The post Student-Developed Wearable ‘Tremor Tracker’ Monitors Parkinson’s Tremors appeared first on Parkinson's News Today.

Read More
share on Twitter Like Student-Developed Wearable ‘Tremor Tracker’ Monitors Parkinson’s Tremors on Facebook

European Project Seeks to Develop Implantable Nanodevices for the Brain to Treat Parkinson’s and Epilepsy

Feb 07, 2020 07:00 am | Mary Chapman

 

early trial resultsA three-year project in Europe seeks to develop nanodevices that could be used as brain implants to treat neurological disorders such as Parkinson’s disease and epilepsy. The European Commission is funding the 3-million euro ($3.3-million) project, called Ion Neuromodulation for Epilepsy Treatment (IN-FET), which aims to create new implantable devices to fundamentally modulate the brain’s electrical […]

The post European Project Seeks to Develop Implantable Nanodevices for the Brain to Treat Parkinson’s and Epilepsy appeared first on Parkinson's News Today.

Read More
share on Twitter Like European Project Seeks to Develop Implantable Nanodevices for the Brain to Treat Parkinson’s and Epilepsy on Facebook

First Patient Dosed in Phase 2 Trial of Oral Treatment to Ease Inflammation in Parkinson’s

Feb 06, 2020 07:00 am | Forest Ray, PhD

 

AKST4290 Phase 2 trialAlkahest announced the dosing of a first patient in the Phase 2 trial for its Parkinson’s therapy AKST4290, an oral tablet aiming to ease the inflammation that can aggravate disease symptoms. The efficacy and safety trial, called AKST4290-211 or TEAL (2019-001657-42), will measure AKST4290’s benefits in motor function and activities relevant to daily life in treated patients relative […]

The post First Patient Dosed in Phase 2 Trial of Oral Treatment to Ease Inflammation in Parkinson’s appeared first on Parkinson's News Today.

Read More
share on Twitter Like First Patient Dosed in Phase 2 Trial of Oral Treatment to Ease Inflammation in Parkinson’s on Facebook

Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases

Feb 06, 2020 07:00 am | Patricia Inacio, PhD

 

radiochemicals studiedA collaborative effort between Fuzionaire Diagnostics, McGill University and The Neuro (Montreal Neurological Institute-Hospital) will foster the development of a new class of radioactive molecules — called radiochemicals — for the diagnosis and treatment of neurodegenerative diseases, including Parkinson’s disease. Radiochemicals are compounds prepared with radioactive elements that are used for medical applications, such as […]

The post Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases appeared first on Parkinson's News Today.

Read More
share on Twitter Like Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases on Facebook

Here’s Why You Should Consider Getting a Dog

Feb 05, 2020 03:00 pm | Mary Beth Skylis

 

dogI’m notorious for attempting to convince everyone in my life to get a dog. I love the furry animals, but I often travel or am in places that aren’t particularly dog-friendly. So my latest mission is to convince my dad to get a dog. Could having a well-trained dog, such as a service dog or […]

The post Here’s Why You Should Consider Getting a Dog appeared first on Parkinson's News Today.

Read More
share on Twitter Like Here’s Why You Should Consider Getting a Dog on Facebook



Recent Posts

Writing Is Hard — but It’s My Lifeline
Oral Treatment in Phase 2 Trial, NYX-458, Seen to Aid Cognition in Primate Model Study
Imaging Analysis Software QyScore Receives FDA Clearance
FDA Clears Way for Phase 2 Trial of AV-101 for Levodopa-Induced Dyskinesia
Parkinson’s Foundation Awards $30K to First 3 Winners of Physical Therapy Faculty Grants

Copyright © 2020 BioNews Inc., All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences